Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
07/18/1996 | CA2210091A1 New applications of lysozyme dimer |
07/17/1996 | EP0721467A1 Use of relaxin as an analgesic and palliative for intractable pain |
07/17/1996 | EP0721349A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
07/17/1996 | EP0721348A1 Monoglyceride/lactate ester permeation enhancer |
07/17/1996 | CN1126999A Peptides exhibiting oxytocin antagonistic activity |
07/16/1996 | US5536752 Phenyl heterocycles as COX-2 inhibitors |
07/16/1996 | US5536714 Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses |
07/11/1996 | WO1996020704A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
07/11/1996 | CA2209276A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
07/10/1996 | EP0720477A1 Method and compositions for maintaining glomerular filtration rate while inhibition extracellular matrix accumulation |
07/10/1996 | CN1126466A Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
07/10/1996 | CN1126439A Compositions for nasal administration of desmopressin |
07/10/1996 | CN1126201A Fullfluoralkyl-substituted bezoylguanidine, preparation, parmaceuticle use of same and pharmaceutical containing same |
07/09/1996 | CA2073601C Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
07/04/1996 | WO1996020207A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
07/04/1996 | WO1996020013A1 Improvements in or relating to endometrial function |
07/04/1996 | WO1996019997A1 Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception |
07/04/1996 | CA2208706A1 Mutants of the rb and p53 genes and uses thereof |
07/04/1996 | CA2208446A1 Improvements in or relating to endometrial function |
07/04/1996 | CA2208321A1 Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception |
07/03/1996 | EP0719860A1 Compositions and method for treating or preventing infections in animals |
07/03/1996 | EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
07/03/1996 | EP0719767A1 Succinamic acid compound, process for producing the same, and use thereof |
07/03/1996 | EP0719551A2 Isolating aminoarginine and use to block nitric oxide formation in body |
07/03/1996 | EP0719146A1 Novel method of progesterone delivery and affect thereof |
07/03/1996 | EP0719143A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
07/03/1996 | EP0719140A1 Use of thiazolidinediones to prevent or delay onset of niddm |
07/03/1996 | EP0719137A1 Viscous surfactant emulsion compositions |
07/03/1996 | CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors |
07/02/1996 | US5532925 Current-to-pressure transducer with selectable, adjustable input filter |
07/02/1996 | US5532245 To reduce smooth muscle contractions; treatment for urinary incontinence, iritable bowel syndrome |
07/02/1996 | US5532235 Tricyclic benzazepine vasopressin antagonists |
07/02/1996 | US5532233 Platelet activating factor antagonist |
07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
06/29/1996 | CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
06/27/1996 | WO1996019195A1 Unitary vaginal dosage form useful as a local contraceptive and/or for combatting sexually transmitted diseases and/or hiv |
06/27/1996 | WO1996019183A1 Formulations and methods for reducing skin irritation |
06/26/1996 | EP0717995A2 Cell degeneration suppressing and organ toxicity reducing agent |
06/26/1996 | EP0717774A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
06/26/1996 | EP0717739A1 Bicyclic aromatic compounds as therapeutic agents |
06/26/1996 | CN1125451A Biologically active vasopressin analogues |
06/26/1996 | CN1125126A Tianlong kidney-supplementing pill |
06/26/1996 | CN1125115A Painless induced labor liquor |
06/25/1996 | US5530019 For treatment of prostate gland disorders |
06/25/1996 | US5530017 Method of antagonizing angiotensin II receptors in mammals using substituted [1H-Imidazol-5-YL] alkenoic acids |
06/25/1996 | US5530009 Treating asthma |
06/20/1996 | WO1996004241A3 Benzoylguanidine derivatives as medicaments |
06/19/1996 | EP0716855A2 Use of estrogen agonists for treating prostatic disease, obesity and bone loss |
06/19/1996 | EP0716648A1 New 9-chloro-prostaglandin derivatives |
06/19/1996 | CN1124926A Pyrazolopyrimidinones for the treatment of impotence |
06/19/1996 | CN1124923A Endothelin receptor antagonists |
06/19/1996 | CN1124648A Preparation of Chinese herbal medicine for constricting woman vagina |
06/19/1996 | CN1124620A Contraceptive |
06/18/1996 | US5527919 Process for the preparation of 1-[(1,1'-biphenyl]-4-YL]-methyl-1H-imidazole-5-carboxylic acids |
06/18/1996 | US5527807 Treating alopecia, acne, prostate disorders |
06/13/1996 | WO1996017953A2 Genetic basis of factor xiii activity |
06/13/1996 | WO1996017863A1 Induction of cytotoxic t-lymphocyte responses |
06/13/1996 | WO1996017831A1 Uracil derivatives |
06/13/1996 | CA2204738A1 Induction of cytotoxic t-lymphocyte responses |
06/12/1996 | EP0716087A1 Heterocyclic amides for control of the potassium channels |
06/12/1996 | EP0715627A1 Indole derivatives as thromboxane a2 antagonists |
06/12/1996 | CN1124485A Novel 1-phenylalkanone 5-HT4 receptor ligands |
06/12/1996 | CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products |
06/12/1996 | CN1031999C Process for preparing 6-substituted-tetrahydrobenz |CD¨ indoles |
06/11/1996 | US5525614 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties |
06/11/1996 | US5525604 4-aminopyrimidine derivatives |
06/11/1996 | CA2030397C 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
06/06/1996 | WO1996016981A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
06/06/1996 | WO1996016657A1 Bicyclic heterocyclic compounds for the treatment of impotence |
06/06/1996 | WO1996016644A1 cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION |
06/06/1996 | WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
06/06/1996 | CA2164375A1 Heterocyclic amides |
06/05/1996 | EP0714894A1 3-(1,2,3,6-tetrahydro-(1-alkylenearyl)-4-pyridinyl)- and 3-(1-alkylenearyl)-4-piperidinyl-1h-indoles: new 5-HT1f agonists |
06/05/1996 | EP0714663A2 Potentiation of drug response by a serotonin 1A receptor antagonist |
06/05/1996 | EP0714300A1 Methods for modulating the human sexual response |
06/04/1996 | US5523309 Benzofuran pharmaceutical compounds |
06/04/1996 | US5523298 Used to induce labor, abortion, menstruation, and againsts hormonal irregularities |
06/04/1996 | US5523094 Aqueous mixture of alfuzosin, organic solvent and absorption promoter |
06/02/1996 | CA2161209A1 3-<1,2,3,6-tetrahydro-<1-alkylenearyl>-4-pyridinyl>- and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-ht1f agonists |
05/30/1996 | WO1996016087A1 G-protein coupled receptor |
05/30/1996 | WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
05/30/1996 | WO1996015794A1 Compositions and methods for contraception and for treatment of benign gynecological disorders |
05/30/1996 | CA2205897A1 Compositions and methods for contraception and for treatment of benign gynecological disorders |
05/29/1996 | EP0713864A1 Substituted benzoylguanidines, process for their preparation, their use as medicament of diagnostic agent as well as medicaments containing them |
05/29/1996 | EP0713653A1 Fortified fruit juice |
05/29/1996 | EP0558647B1 Ligand-mediated immunofunctional hormone binding protein assay method |
05/29/1996 | CN1123545A Guanidine derivatives as inhibitors of Na+/H+ exchange in cells |
05/29/1996 | CN1123159A Bag for curing dysmenorrhoea and preparation method thereof |
05/29/1996 | CA2163840A1 Potentiation of drug response |
05/28/1996 | US5521315 Olefin substituted long chain compounds |
05/28/1996 | US5521216 Treating complications of diabetes |
05/28/1996 | US5521213 Nonsteroid antiinflammatory agents |
05/28/1996 | US5521206 Hypotensive agents, treatment of atherosclerosis |
05/28/1996 | US5521197 Analgesics using serotonin antagonist |
05/28/1996 | US5521177 Angiotensin antagonist for cardiovascular disorders such as ischemia or central nervous system disorders such as cognitive functions, depression, alzheimer's disease or parkinson's syndrome |
05/28/1996 | US5521173 Tricyclic benzazepine vasopressin antagonists |
05/28/1996 | US5521170 Benzamide derivatives and pharmaceutical composition comprising the same |
05/25/1996 | CA2163598A1 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
05/24/1996 | CA2163466A1 Fortified fruit juices |
05/23/1996 | WO1996015103A1 Diaminocyclobutene-3,4-diones |